Core Viewpoint - The article highlights the disparity in fund-raising capabilities between pharmaceutical funds and humanoid robot sector funds, despite the former's strong performance in terms of returns [1][4]. Fund Performance and Growth - The Huatai-PineBridge Hong Kong Advantage Select Fund, which focuses on pharmaceutical stocks, achieved a year-to-date return of 59.77%, ranking second in the market, but only saw a 23% growth in asset size to approximately 2.8 billion yuan [2][4]. - In contrast, funds focused on the humanoid robot sector experienced explosive growth, with some achieving asset size increases of 10 times, 51 times, and 27 times in the same period [1][2]. - The Penghua Carbon Neutral Fund, which also focuses on the humanoid robot sector, saw its asset size surge from 1.1 billion yuan at the beginning of the year to 11.6 billion yuan by the end of March, marking a tenfold increase [2][3]. Market Dynamics - Despite the strong performance of pharmaceutical funds, the market's interest and investment appetite have shifted significantly towards the humanoid robot sector, which is perceived as a high-growth area [4][5]. - The article notes that the asset size of the Huatai-PineBridge fund is only 20% of the Ping An Advanced Manufacturing Theme Fund and 10% of the Qianhai Open Source Jiaxin Mixed Fund, both of which have seen substantial growth in a short time [5][6]. Investment Insights - Fund managers emphasize the importance of a rational approach to investing in the humanoid robot sector, suggesting that investors should consider phased investments due to potential volatility and high valuations [6][7]. - The growth potential in the humanoid robot industry is linked to advancements in artificial intelligence and manufacturing, with expectations for significant developments by 2025 [6][7].

Core Insights - The capital market has experienced a surge in investment in humanoid robots, leading to significant performance in related stocks and funds, resulting in a "Davis Double" effect for several funds heavily invested in this sector [2][4] - Notable funds such as Penghua Carbon Neutral Theme and Yongying Advanced Manufacturing Select have seen substantial growth, with Penghua's fund size increasing over ninefold to surpass 10 billion yuan, and Yongying's fund growing fivefold [2][3] - The rapid expansion of these funds reflects the explosive growth of the humanoid robot industry, although high valuations and volatility indicate potential investment risks [2][5] Fund Performance - Penghua Carbon Neutral Theme A fund achieved a 60.26% return in the first quarter, with its size skyrocketing from 1.035 billion yuan to 10.896 billion yuan, driven by increased investments in key suppliers like Zhongdali De and Zhenyu Technology [2] - Yongying Advanced Manufacturing Select A fund recorded a 52.32% return, growing from 1.762 billion yuan to 11.518 billion yuan, with strategic adjustments in holdings to focus on companies like Zhejiang Rongtai and Zhenyu Technology [3] - The most remarkable case is the Ping An Advanced Manufacturing Theme fund, which grew from 48 million yuan to over 1.321 billion yuan, showcasing a significant turnaround from a "mini fund" status [4] Industry Outlook - Experts believe the humanoid robot industry is still in its early stages, with significant growth potential but also inherent volatility [5] - Predictions indicate that 2025 will mark a pivotal year for "embodied intelligence" robots, with expectations of global production exceeding 10,000 units, signaling the start of mass production [5] - The current investment landscape is characterized by a focus on identifying companies with core technologies that can integrate into the leading robot supply chain, emphasizing a long-term investment strategy [6][7] Investment Strategy - The rapid growth of fund sizes poses challenges for fund managers, as larger funds face increased trading costs and reduced flexibility in managing smaller-cap stocks [6] - Investment professionals recommend a disciplined approach, suggesting that investors consider dollar-cost averaging and diversification to mitigate short-term volatility while capitalizing on long-term growth potential in the humanoid robot sector [7] - Investors are advised to conduct thorough research on the industry and the specific funds before making investment decisions, rather than following trends impulsively [7]

每经记者 任飞 每经编辑 彭水萍 同样是规模大幅提升的案例，偏股混合型基金当中的华富科技动能是目前已公布一季报的同类型基金之 一，A类份额季内净值增长率达到37.12%，位列所有同类型基金第12名。期初这只基金的总规模仅1.08 亿份，季末已升至6.7亿份。 此外，灵活配置型基金当中的长城久鑫，也出现规模的提升，目前也是该类型基金中披露一季报的绩优 产品之一，A类份额一季度净值增长率达到32.7%，位列同类型基金的第五位。基金总规模从期初的 0.21亿份升至0.67亿份，提升幅度明显。 今年一季度，公募基金在发行端取得不错的成绩，存量的绩优产品也顺势获得规模提升的机会。不过， 季内也有不少权益类产品发生大额赎回，甚至有的基金在一季度发生清算。因此，能够在这样分化的市 场当中取得规模的增长，业绩的加持功不可没。 从对标业绩比较基准的差异来看，上述基金均大幅领先业绩比较基准收益率，以初始基金来看，平安先 进制造主题、华富科技动能、长城久鑫分别超越各自业绩比较基准49.07个百分点、37.47个百分点、 33.65个百分点。 紧扣科技投资主线，机器人赛道受关注 近日，公募基金2025年一季报陆续开始披露，一些季内业 ...

每经记者 肖芮冬 每经编辑 叶峰 ｜2025年4月14日星期一｜ NO.1 中信建投基金拟自购2000万元 4月11日，中信建投基金发布公告称，基于对中国资本市场长期健康稳定发展的信心，已于近日运用固 有资金500万元申购旗下中信建投行业轮换混合型证券投资基金A类份额，并承诺上述申购的基金份额 持有期限不低于1年。 此外，中信建投基金拟于未来6个月内，结合市场情况运用公司固有资金择机继续投资旗下权益类公募 基金，预计累计投资金额将达2000万元。 NO.4 本周近2000亿元资金借道ETF进场 本周股指集体调整，沪深两市股票型ETF和跨境型ETF合计净流入近2000亿元。从行业主题看，军工、 消费相关ETF被资金看好，而券商、半导体相关ETF被资金抛售。值得关注的是，本周股票型ETF和跨 境型ETF成交额超200亿元的有15只。 有业内人士表示，增量资金入市意义重大，一方面，充足的流动性注入ETF市场，尤其在市场大幅波动 期间，资金通过借道ETF，可以有效平抑市场震荡，显著提升资本市场稳定性。另一方面，保险资金、 养老金、社保基金等机构投资者为ETF市场带来大量增量资金。这些资金具备长期投资属性，有助于优 化 ...